6-phosphogluconate dehydrogenase deficiency: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Line 38: Line 38:
[[Category:Metabolic disorders]]
[[Category:Metabolic disorders]]
[[Category:Enzyme deficiencies]]
[[Category:Enzyme deficiencies]]
<gallery>
File:PDB_1pgq_EBI.jpg|Structure of 6-phosphogluconate dehydrogenase
File:6-phosphogluconate_dehydrogenase_deficiency.png|6-phosphogluconate dehydrogenase deficiency
</gallery>

Revision as of 01:18, 18 February 2025

6-Phosphogluconate Dehydrogenase Deficiency

Structure of 6-phosphogluconate dehydrogenase
Pathway involving 6-phosphogluconate dehydrogenase

6-Phosphogluconate dehydrogenase deficiency is a rare metabolic disorder that affects the pentose phosphate pathway, specifically the oxidative phase. This deficiency is due to a lack of the enzyme 6-phosphogluconate dehydrogenase, which plays a crucial role in the conversion of 6-phosphogluconate to ribulose 5-phosphate.

Pathophysiology

The pentose phosphate pathway is essential for the production of NADPH and ribose 5-phosphate. NADPH is crucial for biosynthetic reactions and for maintaining the redox state of cells by regenerating glutathione. In 6-phosphogluconate dehydrogenase deficiency, the reduced activity of the enzyme leads to decreased NADPH production, which can impair the cell's ability to handle oxidative stress.

Clinical Manifestations

Individuals with 6-phosphogluconate dehydrogenase deficiency may present with symptoms similar to those seen in other red blood cell enzymopathies, such as hemolytic anemia. Symptoms can include fatigue, jaundice, and pallor. The severity of symptoms can vary widely among affected individuals.

Diagnosis

Diagnosis of 6-phosphogluconate dehydrogenase deficiency is typically made through biochemical assays that measure the activity of the enzyme in red blood cells. Genetic testing can also be used to identify mutations in the gene encoding 6-phosphogluconate dehydrogenase.

Treatment

There is no specific treatment for 6-phosphogluconate dehydrogenase deficiency. Management focuses on avoiding triggers of hemolysis, such as certain drugs and infections. In cases of severe anemia, blood transfusions may be necessary.

Related Pages

Gallery